Skip to main content
The BMJ logoLink to The BMJ
. 1993 Oct 2;307(6908):849–852. doi: 10.1136/bmj.307.6908.849

Screening for carriers of cystic fibrosis--a general practitioner's perspective.

M Modell 1
PMCID: PMC1678878  PMID: 8401130

Abstract

The identification of the gene for cystic fibrosis has led to the possibility of population based screening for carriers of cystic fibrosis to identify couples at risk of having an affected child. Pilot studies have shown that screening is feasible and does not cause untoward anxiety, though the uptake of testing varies considerably with the setting and method of invitation. Screening offered at times when individuals (and health professionals) perceive it as directly relevant will probably gradually become established in the United Kingdom. This review examines the role of general practice in genetic carrier screening as exemplified by cystic fibrosis. General practice has a pivotal role from the beginning in providing individuals and couples with information, facilitating testing of patients' relatives and of carriers identified by screening elsewhere (such as antenatal clinics), and offering testing in the context of reproduction. Screening for the cystic fibrosis gene will probably be followed by other genetic screening programmes.

Full text

PDF
849

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bekker H., Modell M., Denniss G., Silver A., Mathew C., Bobrow M., Marteau T. Uptake of cystic fibrosis testing in primary care: supply push or demand pull? BMJ. 1993 Jun 12;306(6892):1584–1586. doi: 10.1136/bmj.306.6892.1584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Borgo G., Fabiano T., Perobelli S., Mastella G. Effect of introducing prenatal diagnosis on the reproductive behaviour of families at risk for cystic fibrosis. A cohort study. Prenat Diagn. 1992 Oct;12(10):821–830. doi: 10.1002/pd.1970121008. [DOI] [PubMed] [Google Scholar]
  3. Boué J., Muller F., Simon-Bouy B., Faure C., Boué A. Consequences of prenatal diagnosis of cystic fibrosis on the reproductive attitudes of parents of affected children. Prenat Diagn. 1991 Apr;11(4):209–214. doi: 10.1002/pd.1970110402. [DOI] [PubMed] [Google Scholar]
  4. Burn J. Screening for cystic fibrosis in primary care. BMJ. 1993 Jun 12;306(6892):1558–1559. doi: 10.1136/bmj.306.6892.1558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Harris C. P., Baringer J. R. Drs harris and baringer respond. West J Med. 1992 Apr;156(4):437–437. [PMC free article] [PubMed] [Google Scholar]
  6. Harris H. J., Scotcher D., Craufurd D., Wallace A., Harris R. Cystic fibrosis carrier screening at first diagnosis of pregnancy in general practice. Lancet. 1992 Jun 20;339(8808):1539–1539. doi: 10.1016/0140-6736(92)91303-p. [DOI] [PubMed] [Google Scholar]
  7. Harris H., Scotcher D., Hartley N., Wallace A., Craufurd D., Harris R. Cystic fibrosis carrier testing in early pregnancy by general practitioners. BMJ. 1993 Jun 12;306(6892):1580–1583. doi: 10.1136/bmj.306.6892.1580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Magnay D., Wilson O., el Hait S., Balhamar M., Burn J. Carrier testing for cystic fibrosis: knowledge and attitudes within a local community. J R Coll Physicians Lond. 1992 Jan;26(1):69–70. [PMC free article] [PubMed] [Google Scholar]
  9. Mennie M. E., Gilfillan A., Compton M., Curtis L., Liston W. A., Pullen I., Whyte D. A., Brock D. J. Prenatal screening for cystic fibrosis. Lancet. 1992 Jul 25;340(8813):214–216. doi: 10.1016/0140-6736(92)90476-j. [DOI] [PubMed] [Google Scholar]
  10. Modell B., Ward R. H., Fairweather D. V. Effect of introducing antenatal diagnosis on reproductive behaviour of families at risk for thalassaemia major. Br Med J. 1980 Jun 7;280(6228):1347–1350. doi: 10.1136/bmj.280.6228.1347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Riordan J. R., Rommens J. M., Kerem B., Alon N., Rozmahel R., Grzelczak Z., Zielenski J., Lok S., Plavsic N., Chou J. L. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989 Sep 8;245(4922):1066–1073. doi: 10.1126/science.2475911. [DOI] [PubMed] [Google Scholar]
  12. Robson M., Abbott J., Webb K., Dodd M., Walsworth-Bell J. A cost description of an adult cystic fibrosis unit and cost analyses of different categories of patients. Thorax. 1992 Sep;47(9):684–689. doi: 10.1136/thx.47.9.684. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Super M., Schwarz M. J., Malone G. Screening for cystic fibrosis carriers. Lancet. 1992 Aug 22;340(8817):490–491. doi: 10.1016/0140-6736(92)91816-q. [DOI] [PubMed] [Google Scholar]
  14. Tsui L. C. The spectrum of cystic fibrosis mutations. Trends Genet. 1992 Nov;8(11):392–398. doi: 10.1016/0168-9525(92)90301-j. [DOI] [PubMed] [Google Scholar]
  15. Wald N. J. Couple screening for cystic fibrosis. Lancet. 1991 Nov 23;338(8778):1318–1319. doi: 10.1016/0140-6736(91)92605-2. [DOI] [PubMed] [Google Scholar]
  16. Walters S., Britton J., Hodson M. E. Demographic and social characteristics of adults with cystic fibrosis in the United Kingdom. BMJ. 1993 Feb 27;306(6877):549–552. doi: 10.1136/bmj.306.6877.549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Watson E. K., Mayall E. S., Lamb J., Chapple J., Williamson R. Psychological and social consequences of community carrier screening programme for cystic fibrosis. Lancet. 1992 Jul 25;340(8813):217–220. doi: 10.1016/0140-6736(92)90477-k. [DOI] [PubMed] [Google Scholar]
  18. Watson E. K., Mayall E., Chapple J., Dalziel M., Harrington K., Williams C., Williamson R. Screening for carriers of cystic fibrosis through primary health care services. BMJ. 1991 Aug 31;303(6801):504–507. doi: 10.1136/bmj.303.6801.504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Williamson R. Universal community carrier screening for cystic fibrosis? Nat Genet. 1993 Mar;3(3):195–201. doi: 10.1038/ng0393-195. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES